Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

NICE news for mifamurtide, tocilizumab and ticagrelor

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    NICE news for mifamurtide, tocilizumab and ticagrelor. Pharmacoecon. Outcomes News 641, 10 (2011). https://doi.org/10.2165/00151234-201106410-00030

    Download citation

    Keywords

    • Methotrexate
    • Acute Coronary Syndrome
    • Osteosarcoma
    • Medium Release
    • Tocilizumab